Skip to content
Sign in
European CDMOs compared · 2026 census

CDMOs in Denmark: 7 compared (2026)

7 of the 255 contract development and manufacturing organisations in A4BEE’s European census are headquartered in Denmark. The largest, with revenue over €1bn, are AGC Biologics. 3 sit between €250m and €1bn and 3 are smaller or niche.

By ownership: 1 family-owned, 1 private equity, 4 part of a pharma or industrial group and 1 state-owned. The most common capabilities are microbial and protein (4), monoclonal antibody (2), oral solid dose (2), small-molecule API (2) and biologics and biosimilars (2). 5 of the 7 rows rest on audited reports or official company disclosures; the rest come from secondary sources or estimates.

Open these 7 in the interactive mapAll 255 European CDMOs

7 companies

CDMOs in Denmark

CompanyHQOwnershipSizeRevenue (as reported)ModalitiesData
AGC BiologicsCopenhagen site expanded to 16,000 L single-use; broad multi-modality platform.CopenhagenPart of a pharma or industrial groupAGC Inc.Tier 1~US$1.2 bn (global)Monoclonal antibody, Microbial and protein, mRNA and LNP, Viral vector and vaccine, Cell and gene therapymedium
Fertin PharmaSpecialist CDMO for oral/intra-oral delivery (medicated gum, pouches, liquefiable tablets); leading NRT producer. Owned by PMI.VejlePart of a pharma or industrial groupPhilip Morris InternationalTier 2not disclosedOral solid dosehigh
Novo Nordisk PharmatechThird-party supplier of quaternary ammonium APIs/excipients, recombinant insulin for media, and recombinant enzymes. Sells to external customers.KøgePart of a pharma or industrial groupNovo NordiskTier 2not disclosedSmall-molecule API, Microbial and protein, Biologics and biosimilarshigh
Xellia PharmaceuticalsFermentation-based non-beta-lactam anti-infectives; APIs + FDF to 500+ pharma companies, plus CMO/CDMO services. Phasing out Copenhagen manufacturing.CopenhagenPart of a pharma or industrial groupNovo HoldingsTier 2not disclosedSmall-molecule API, Sterile fill-finish, Microbial and proteinhigh
BioneerCombined CRO + CDMO; process dev and GMP/non-GMP manufacturing of recombinant proteins/enzymes. Not-for-profit GTS institute, DTU subsidiary.HørsholmState-ownedTechnical University of DenmarkTier 3not disclosedBiologics and biosimilars, Microbial and protein, Monoclonal antibodyhigh
Pharma-SkanIndependent CMO producing/filling liquid and sterile pharmaceuticals and oral liquids for human and veterinary use.SkanderborgPrivate equityBrygge PartnersTier 3not disclosedSterile fill-finishmedium
ScanpharmGMP family-owned combined CMO and contract laboratory (est. 1951); tablets incl. packaging, serialization, testing; small own niche-generics portfolio.BirkerødFamily-ownedTier 3not disclosedOral solid dosehigh

Size: Tier 1 (revenue over €1bn) · Tier 2 (€250m–€1bn) · Tier 3 (under €250m or niche).

Revenue, staff and site figures are as reported and mix audited accounts with commercial estimates, which are often wrong for private companies. Each row carries a confidence mark; verify a figure before quoting it.

Browse the census

Other European CDMO lists